EGFR and non-small cell lung carcinoma: Our research group has examined whether genomic alterations of non‐small cell lung cancer (NSCLC) can be detected by ctDNA analysis, and their correlation with tumor progression, starting with the HASAT study that focused on EGFR T790 M.4